HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

CCR2 signaling contributes to ischemia-reperfusion injury in kidney.

Abstract
Examined were CCR2-deficient mice to clarify the contribution of macrophages via monocyte chemoattractant protein 1 (MCP-1 or CCL2)/CCR2 signaling to the pathogenesis of renal ischemia-reperfusion injury. Also evaluated was the therapeutic effects via the inhibition of MCP-1/CCR2 signaling with propagermanium (3-oxygermylpropionic acid polymer) and RS-504393. Renal artery and vein of the left kidney were occluded with a vascular clamp for 60 min. A large number of infiltrated cells and marked acute tubular necrosis in outer medulla after renal ischemia-reperfusion injury was observed. Ischemia-reperfusion induced the expression of MCP-1 mRNA and protein in injured kidneys, followed by CCR2-positive macrophages in interstitium in wild-type mice. The expression of MCP-1 was decreased in CCR2-deficient mice compared with wild-type mice. The number of interstitial infiltrated macrophages was markedly smaller in the CCR2-deficient mice after ischemia-reperfusion. CCR2-deficient mice decreased the number of interstitial inducible nitric oxide synthase-positive cells after ischemia-reperfusion. The area of tubular necrosis in CCR2-deficient mice was significantly lower than that of wild-type mice after ischemia-reperfusion. In addition, CCR2-deficient mice diminished KC, macrophage inflammatory protein 2, epithelial cell-derived neutrophil-activating peptide 78, and neutrophil-activating peptide 2 expression compared with wild-type mice accompanied with the reduction of interstitial granulocyte infiltration. Similarly, propagermanium and RS-504393 reduced the number of interstitial infiltrated cells and tubular necrosis up to 96 h after ischemia-reperfusion injury. These results revealed that MCP-1 via CCR2 signaling plays a key role in the pathogenesis of renal ischemia-reperfusion injury through infiltration and activation of macrophages, and it offers a therapeutic target for ischemia-reperfusion.
AuthorsKengo Furuichi, Takashi Wada, Yasunori Iwata, Kiyoki Kitagawa, Ken-Ichi Kobayashi, Hiroyuki Hashimoto, Yoshiro Ishiwata, Masahide Asano, Hui Wang, Kouji Matsushima, Motohiro Takeya, William A Kuziel, Naofumi Mukaida, Hitoshi Yokoyama
JournalJournal of the American Society of Nephrology : JASN (J Am Soc Nephrol) Vol. 14 Issue 10 Pg. 2503-15 (Oct 2003) ISSN: 1046-6673 [Print] United States
PMID14514728 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Ccr2 protein, mouse
  • Chemokine CCL2
  • Interferon Inducers
  • Organometallic Compounds
  • Propionates
  • RNA, Messenger
  • Receptors, CCR2
  • Receptors, Chemokine
  • Germanium
  • propagermanium
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type II
  • Nos2 protein, mouse
Topics
  • Animals
  • Chemokine CCL2 (genetics)
  • Chemotaxis, Leukocyte (immunology)
  • Gene Expression (immunology)
  • Germanium
  • Granulocytes (cytology)
  • Interferon Inducers (pharmacology)
  • Kidney (physiology)
  • Kidney Tubular Necrosis, Acute (metabolism)
  • Macrophages (cytology, physiology)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Inbred ICR
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type II
  • Organometallic Compounds (pharmacology)
  • Propionates
  • RNA, Messenger (metabolism)
  • Receptors, CCR2
  • Receptors, Chemokine (metabolism)
  • Reperfusion Injury (metabolism)
  • Signal Transduction (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: